Catalyst Wire Dossier Catalyst Wire Dossier

Gefitinib Mylan

Gefitinib · Mylan Pharmaceuticals Limited
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Gefitinib Mylan, covering 2024-10-17 to 2024-10-17. Get the full timeline:

Most recent: EMA Withdrawn: Gefitinib Mylan (gefitinib) — Mylan Pharmaceuticals Limited

See pricing